Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results From the Phase 2b Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

被引：0
|
作者：
Gilbert, D. L.
Karkanias, G. B.
Atkinson, S. D.
Munschauer, F.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2025年 / 96卷
关键词：
Experimental Therapeutics; Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
97
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial
    Hordinsky, Maria
    Hebert, Adelaide A.
    Gooderham, Melinda
    Kwon, Ohsang
    Murashkin, Nikolay
    Fang, Hong
    Harada, Kazutoshi
    Law, Ernest
    Wajsbrot, Dalia
    Takiya, Liza
    Zwillich, Samuel H.
    Wolk, Robert
    Tran, Helen
    PEDIATRIC DERMATOLOGY, 2023, 40 (06) : 1003 - 1009
  • [22] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
    Pariser, David M.
    Bagel, Jerry
    Lebwohl, Mark
    Yosipovitch, Gil
    Chien, Elaine
    Spellman, Mary C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
  • [23] Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab
    Ayer, David W.
    Skljarevski, Vladimir
    Ford, Janet H.
    Nyhuis, Allen W.
    Lipton, Richard B.
    Aurora, Sheena K.
    HEADACHE, 2018, 58 (08): : 1225 - 1235
  • [24] The Effect of Tenapanor on Global Endpoints in Patients with Constipation Predominant Irritable Bowel Syndrome: Results from a 12-Week, Double-Blind, Placebo-Controlled, Randomized Phase 2b Trial
    Chey, William D.
    Lembo, Anthony J.
    Rosenbaum, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S236 - S236
  • [25] Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial
    Melby, Katrine
    Grawe, Rolf W.
    Aamo, Trond O.
    Salvesen, Oyvind
    Spigset, Olav
    DRUG AND ALCOHOL DEPENDENCE, 2019, 197 : 95 - 101
  • [26] A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial
    Mathew, Sanjay J.
    Vythilingam, Meena
    Murrough, James W.
    Zarate, Carlos A., Jr.
    Feder, Adriana
    Luckenbaugh, David A.
    Kinkead, Becky
    Parides, Michael K.
    Trist, David G.
    Bani, Massimo S.
    Bettica, Paolo U.
    Ratti, Emiliangelo M.
    Charney, Dennis S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (03) : 221 - 229
  • [27] A randomized, double-blind, placebo-controlled clinical trial to investigate the effect of Cynatine® HNS on skin characteristics
    Beer, C.
    Wood, S.
    Veghte, R. H.
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2013, 35 (06) : 608 - 612
  • [28] SERLOPITANT FOR TREATMENT OF CHRONIC PRURITUS: RESULTS OF A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL
    Yosipovitch, Gil
    Stander, Sonja
    Kerby, Matthew B.
    Larrick, James W.
    Perlman, Andrew J.
    Schnipper, Edward F.
    Zhang, Xiaoming
    Tang, Jean Y.
    Luger, Thomas A.
    Steinhoff, Martin
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1015 - 1015
  • [29] A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia
    Kalliomaki, Jarkko
    Attal, Nadine
    Jonzon, Bror
    Bach, Flemming W.
    Huizar, Karin
    Ratcliffe, Stuart
    Eriksson, Britta
    Janecki, Marcin
    Danilov, Andrei
    Bouhassira, Didier
    PAIN, 2013, 154 (05) : 761 - 767
  • [30] Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
    Opal, SM
    Fisher, CJ
    Dhainaut, JFA
    Vincent, JL
    Brase, R
    Lowry, SF
    Sadoff, JC
    Slotman, GJ
    Levy, H
    Balk, RA
    Shelly, MP
    Pribble, JP
    LaBrecque, JF
    Lookabaugh, J
    Donovan, H
    Dubin, H
    Baughman, R
    Norman, J
    DeMaria, E
    Matzel, K
    Abraham, E
    Seneff, M
    Barber, A
    Brayman, K
    Cerra, F
    Chalfin, D
    Chazen, G
    Christou, N
    Cooney, R
    Corbin, R
    Drew, R
    Emmanuel, G
    Pines, B
    Eron, L
    Fletcher, R
    Foulke, G
    Gallagher, T
    Gervich, D
    Grossman, J
    Halpern, N
    Hanna, C
    Johnson, S
    Kubak, B
    Lodato, R
    Lovett, M
    Marshall, J
    Metzler, M
    Nelson, L
    Freeland, M
    Oropello, J
    CRITICAL CARE MEDICINE, 1997, 25 (07) : 1115 - 1124
12345